FMR LLC & Abigail Johnson Report 11.989% Stake in Nuvation Bio
Ticker: NUVB · Form: SC 13G/A · Filed: Feb 9, 2024 · CIK: 1811063
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, passive-investment, amendment, biotech
TL;DR
**FMR LLC and Abigail Johnson still own nearly 12% of Nuvation Bio, showing continued institutional interest.**
AI Summary
FMR LLC, a major investment firm, and its CEO, Abigail P. Johnson, have updated their ownership in Nuvation Bio Inc. (NUVB) Class A Common Stock. As of February 9, 2024, they collectively beneficially own 26,130,659 shares, representing 11.989% of the company. This filing, an amendment to a previous Schedule 13G, indicates a significant, but slightly reduced, passive stake in the pharmaceutical company, which could signal FMR's ongoing confidence or a minor rebalancing of their portfolio.
Why It Matters
This filing shows that a major institutional investor, FMR LLC, and its leader, Abigail P. Johnson, maintain a substantial stake in Nuvation Bio, which can influence investor perception and potentially provide a degree of stability to the stock.
Risk Assessment
Risk Level: low — This filing indicates a passive investment by a large institution, which generally poses low direct risk to the company's operations or stock price.
Analyst Insight
Investors should note the continued institutional interest from FMR LLC, but recognize this is a passive stake, meaning FMR is not actively seeking to influence management. This filing provides stability but no immediate catalyst.
Key Numbers
- 26,130,659 — Shares Beneficially Owned (Total Class A Common Stock shares held by FMR LLC and Abigail P. Johnson in Nuvation Bio Inc.)
- 11.989% — Percentage of Class (The proportion of Nuvation Bio Inc.'s Class A Common Stock owned by FMR LLC and Abigail P. Johnson.)
Key Players & Entities
- FMR LLC (company) — reporting person and parent holding company
- Abigail P. Johnson (person) — reporting person, associated with FMR LLC
- Nuvation Bio Inc. (company) — subject company, issuer of the securities
- 26,130,659 (dollar_amount) — total shares beneficially owned
- 11.989% (dollar_amount) — percentage of Class A Common Stock owned
Forward-Looking Statements
- FMR LLC will maintain a significant, passive stake in Nuvation Bio Inc. for the foreseeable future. (FMR LLC) — high confidence, target: 2025-02-09
FAQ
Who are the primary reporting persons in this SC 13G/A filing for Nuvation Bio Inc.?
The primary reporting persons are FMR LLC and Abigail P. Johnson, as stated in Item 1 of the filing for both entities.
What is the total number of Class A Common Stock shares of Nuvation Bio Inc. beneficially owned by FMR LLC and Abigail P. Johnson?
Both FMR LLC and Abigail P. Johnson beneficially own 26,130,659 shares of Nuvation Bio Inc. Class A Common Stock, as indicated in Item 7 for both reporting persons and Item 4(a) for FMR LLC.
What percentage of Nuvation Bio Inc.'s Class A Common Stock do the reporting persons collectively own?
The reporting persons, FMR LLC and Abigail P. Johnson, collectively own 11.989% of Nuvation Bio Inc.'s Class A Common Stock, as stated in Item 11 for both entities and Item 4(b) for FMR LLC.
Under which rule is this Schedule 13G/A filed?
This Schedule 13G/A is filed pursuant to Rule 13d-1(b), as indicated by the checked box in the filing and explicitly stated in Item 3 for FMR LLC.
What is the CUSIP number for Nuvation Bio Inc.'s Class A Common Stock?
The CUSIP number for Nuvation Bio Inc.'s Class A Common Stock is 67080N101, as listed multiple times in the filing, including under 'Cusip #67080N101' and Item 2(e).
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 9, 2024 by Abigail P. Johnson regarding Nuvation Bio Inc. (NUVB).